A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes

Clinical trial NCT06894784 · RECRUITING

Trial details

NCT number: NCT06894784
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Type 1

Start date: 2025-04-01
Primary completion: 2027-01-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.